Señales en vivo de RUA.L | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 07:21):

RUA Life Sciences plc, together with its subsidiaries, provides polymers, services, and products to the medical device industry in Europe, the United States, and internationally...

Stats
Volumen de hoy	99 476.00
Volumen promedio	673 797
Capitalización de mercado	6.95M
EPS	£0 ( 2023-12-19 )
Próxima fecha de ganancias	( £0 ) 2024-07-23
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	-1.450
ATR14	£0.149 (1.28%)

Volumen Correlación

Largo: -0.15 (neutral)

Corto: -0.53 (weak negative)

Signal:(54.777) Neutral

Rua Life Sciences PLC Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Rua Life Sciences PLC Correlación - Moneda/Commodity

0.38
( neutral )

0.49
( neutral )

0.00
( neutral )

0.51
( weak )

-0.07
( neutral )

-0.10
( neutral )

Rua Life Sciences PLC Finanzas

Annual	2022
Ingresos:	£2.18M
Beneficio Bruto:	£1.43M (65.76 %)
EPS:	£-0.0903

FY	2022
Ingresos:	£2.18M
Beneficio Bruto:	£1.43M (65.76 %)
EPS:	£-0.0903

FY	2022
Ingresos:	£1.63M
Beneficio Bruto:	£1.36M (83.57 %)
EPS:	£-0.0932

FY	2021
Ingresos:	£1.53M
Beneficio Bruto:	£1.25M (81.94 %)
EPS:	£-0.0820

Financial Reports:

No articles found.

Rua Life Sciences PLC

RUA Life Sciences plc, together with its subsidiaries, provides polymers, services, and products to the medical device industry in Europe, the United States, and internationally. The company operates as a contract developer and manufacturer of medical devices; and licensor of Elast-Eon and ECSil implantable co-polymers that are used in cardiology and urological applications, including pacing leads, cardiac cannulae, and stent devices, as well as reaction injection molding technology for use in high-precision medical device components. It also develops bore polymer sealed grafts and soft tissue patches; and tri leaflet polymeric heart valves. The company was formerly known as AorTech International plc and changed its name to RUA Life Sciences plc in June 2020. RUA Life Sciences plc was incorporated in 1996 and is headquartered in Irvine, the United Kingdom.